Upgrade to SI Premium - Free Trial

Neurocrine Bio. (NBIX) PT Raised to $99 at Deutsche Bank

May 1, 2018 7:40 AM
Deutsche Bank raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $99.00 (from $97.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles